Steroid News and Research

RSS

Researchers recommend multidisciplinary approach of low back pain

Researchers calculated the costs of management of low back pain and found that an integrated and step-wise approach within a multidisciplinary setting forms a better use of the available resources. The study is published in the September issue of Pain Practice.

7 Sep 2005

Immunosuppressive drug mycophenolate mofetil may be effective in controlling inflammatory eye diseases

The immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases, according to a study by Johns Hopkins' Wilmer Eye Institute.

4 Sep 2005

Contraceptive pill controls severe premenstrual disorder

According to a new study, a low dose oral contraceptive works as a treatment for the most severe form of premenstrual syndrome, premenstrual dysphoric disorder (PMDD).

1 Sep 2005

Low dose oral contraceptive effective in controlling premenstrual disorder

A new study led by researchers at Yale School of Medicine shows for the first time that a low dose oral contraceptive with a unique progestin and dosing regimen is effective in treating symptoms of premenstrual dysphoric disorder (PMDD), the most severe form of premenstrual syndrome.

31 Aug 2005

Ways to avoid hazards of heart bypass under study

The heart-lung bypass machine that stills the heart while surgeons bypass an adult’s clogged arteries or repair a baby’s malformed heart can also trigger a potentially deadly inflammatory response.

28 Aug 2005

Experimental immunusuppressant drug preserves transplanted kidneys

An international team of transplant physicians has shown that the investigational drug belatacept (LEA29Y) preserves transplanted kidney function as effectively as cyclosporine, the drug most commonly used to prevent the immune system from rejecting transplanted organs.

24 Aug 2005

New hope for those deaf from immune system attack

A new study may one day help those deafened by immune system attack, and possibly also lead to a test that could show which patients may be helped by immediate steroid treatment.

16 Aug 2005

Liquid detergent capsules can cause serious damage to childrens eyes

According to a recently released report, during a 6-month period, doctors treated six cases of severe eye injuries in young children, caused by their squeezing capsules containing liquid washing detergent.

15 Aug 2005

Plasma exchange treatment shown most helpful for severe attacks in subtype of MS patients

A Mayo Clinic study demonstrates that only those multiple sclerosis (MS) patients with evidence for antibody deposition or complement activation -- immune cells that can cause tissue destruction -- in their lesions are likely to respond to plasma exchange, a treatment for acute MS attacks.

11 Aug 2005

Alternative to Cox II inhibitors

After the failure of cox II inhibitors such as Vioxx, osteoarthritis patients and their doctors are faced with a lack of alternative therapies. The Orthokine-therapy means knee-injections of IL-1Ra protein, obtained from the patient's blood.

11 Aug 2005

Australian scientists rejuvenate the immune systems of mice and humans using a common hormone

The scientists, led by Associate Professor Richard Boyd and Dr Jayne Sutherland from the Monash Immunology and Stem Cell Laboratories, have revitalised the thymus which produces the T cells required to fight infection but which shuts down from early adulthood.

11 Aug 2005

Nationwide survey reports a high rate of concern about body image in both boys and girls

A nationwide survey of more than 10,000 adolescents, published in the August issue of Pediatrics, reports a high rate of concern about body image in both boys and girls, and finds that adolescents with such concerns are much more likely to use hormones and dietary supplements to enhance their physique.

1 Aug 2005

Gene that regulates normal embryonic development is found at high levels in virtually all forms of breast cancer

A gene that appears to help regulate normal embryonic development is found at high levels in virtually all forms of breast cancer, according to a new study led by Laszlo Radvanyi, Ph.D., associate professor of breast and melanoma medical oncology at The University of Texas M. D. Anderson Cancer Center.

25 Jul 2005

Prescription drug abuse in the USA exceeds 15 million

A recently released report by the National Center on Addiction and Substance Abuse at Columbia University suggests between 1992 and 2003, more Americans were abusing controlled prescription drugs than cocaine, hallucinogens, inhalants and heroin put together.

11 Jul 2005

Sex hormone levels not linked to low sexual desire

No single androgen (sex hormone) level was found to be predictive of low sexual function in women, according to a study in the July 6 issue of JAMA.

6 Jul 2005

Powerful steroids could be avoided in many cases of childhood eczema

An expert at the University of Sheffield will be talking about the causes for the increased incidence of eczema in children in a Channel Four documentary, Allergic to Everything on Thursday 30 June at 9pm.

27 Jun 2005

Antifungal drug could improve lives of thousands of asthmatics

Researchers in the UK say that antifungal drugs could be the key to improving the lives of thousands of asthmatics.

From The University of Manchester 16 Jun 2005

Key milestone in study of the antifungal treatment of asthma

University of Manchester researchers announced today that they have reached a key milestone in their study of the antifungal treatment of asthma.

From The University of Manchester 15 Jun 2005

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Professor Paul Emery from the University of Leeds in the UK led the DANCER study (Double blind placebo controlled dose ranging study), designed to confirm the efficacy of rituximab for the treatment of patients with active RA who have failed to improve on one or more disease modifying anti-rheumatic drugs (DMARDs).

9 Jun 2005

Rituximab provides new hope for people with lupus

Rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria heard today (Thursday 9 June) that rituximab is the first drug in a quarter of a century that is making a real impact, and an alternative to previous standard treatments of high-dose steroids, and chemotherapy.

9 Jun 2005